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A B S T R A C T
Two experiments were carried out to evaluate the bactericidal impacts of Bacillus amyloliquefaciens CECT 5940
on the shedding of faecal pathogenic bacteria in dairy calves (Experiment 1) and in adults dogs (experiment 2).
In the calves experiment, a completely randomized design was used to investigate the faecal bacteria proﬁle of
Holstein dairy calves fed with either pasteurized waste milk (PWM; n = 9) or a formulated non-medicated milk
replacer (NMR; n = 9) for 60 d. The NMR containing sodium-butyrate and the active probiotic
B. amyloliquefaciens CECT 5940. In the dogs experiment, addition of same probiotic (i.e., B. amyloliquefaciens
CECT 5940) was carried out in two stages. The ﬁrst stage started from day 7–37, and the second from day 44–71.
The assessment of faecal score measured on day 22, 37, 42, 57, 71 and 77 to determine the texture of the stools.
Calves received PWM consumed (P < 0.05) more starter feed between day 16 and day 45. The calves fed NMR
had more moisture faeces and less cough reﬂux than the PWM-calves. Feeding NMR to calves increased faecal
Klebsiella oxytoca and Proteus vulgaris counts in comparison to PWM-calves. The administration of
B. amyloliquefaciens CECT 5940 to the dog diet has no signiﬁcant eﬀect on the hardness of the stool. Meanwhile,
the bacillus count increases while the coliforms count decreases upon B. amyloliquefaciens CECT 5940 admin-
istration. This reveals that B. amyloliquefaciens CECT 5940 survived the gastrointestinal passage and rapidly
colonized the dog intestine, which could positively aﬀect the metabolism and composition of the intestinal
microﬂora. These results show that B. amyloliquefaciens are a promising probiotic with an antimicrobial and
bactericidal activities against the intestinal pathogenic bacteria for dairy calves and adult dogs.
1. Introduction
In dairy calves, increasing interest is paid to dairy calf growth by
improving the early life nutrition, based on increased liquid feeding to
enhance calf survival and growth [1–3]. Waste milk is a non-saleable
transition milk from cows or milk from cows treated with antibiotics.
Waste milk is generally not suitable for human intake; however, it
contains essential nutrients that can support calf growth. Godden et al.
[2] showed in the USA that about 22–62 kg of waste milk is wasted per
cow yearly. This lead to a large economic loss to the dairy industry.
However, feeding raw non-saleable waste milk may pose risks for the
transmission of infectious pathogens, such as Mycobacterium avium,
Mycobacterium bovis, Listeria monocytogenes, Escherichia coli, Salmonella
sp., Mycoplasma, and Campylobacter. Stabel et al. [4] reported that
pasteurization is an active method to destroy common pathogenic
bacteria species, presented in waste milk.
Non-medicated milk replacer (NMR) is widely used to replace whole
milk for dairy calf feeding and can be manufactured with a variety of
ingredients and levels of nutrient with additives, such as vitamins,
antibiotics, coccidiostats, probiotics and ionophores to better support
calf growth [1,5,6]. Elghandour et al. [7], in their review, reported less
incidence and duration of diarrhea in calves that consumed probiotics
(e.g. Saccharomyces cerevisiae, Bacillus amyloliquefaciens and Sacchar-
omyces boulardii), which may reduce mortality and morbidity of neo-
natal calves as a result of reduction of pathogenic bacteria such as
Salmonella and E. coli [8]. Supplementation with probiotic may accel-
erate the formation of intestinal and ruminal microorganisms and re-
duce the formation of enteropathogens, which often cause diarrhea [7].
https://doi.org/10.1016/j.micpath.2017.11.040
Received 2 November 2017; Received in revised form 20 November 2017; Accepted 23 November 2017
∗ Corresponding author.
E-mail address: asalem70@yahoo.com (A.Z.M. Salem).
Microbial Pathogenesis 114 (2018) 458–463
Available online 24 November 2017
0882-4010/ © 2017 Elsevier Ltd. All rights reserved.
T
Probiotics also confer a health beneﬁt to dogs. The mechanisms of
action include regulation of microbial homeostasis in the intestine,
stabilization of the gastrointestinal barrier, expression of bacteriocins,
an enzymatic activity that enhances nutrient digestibility, immune
modulator eﬀects, and interference with the ability of pathogens to bind
to the intestinal wall [9]. Moreover, the normal composition of the
intestinal microﬂora in dogs can be altered by hectic conditions, such as
oral administration of antibiotics, gastrointestinal infections, dietary
changes, and weaning.
In this context, the addition of a probiotic to the diet of pets is a way
to improve intestinal health, preventing gastrointestinal disorders, and
as a consequence, improving coexistence with the owners. In this vein,
Buddington et al. [10], demonstrated that a combination of B. amyloli-
quefaciens and E. faecium decreases the concentration of Clostridium spp.
pathogen. The ability of Bacillus to survive through the digestive pro-
cess, germination within the digestive tract, and defecation via faecal
matter makes it the most promising [11].
B. amyloliquefaciens is a strong strain of Bacillus, which is capable of
producing extracellular enzymes like cellulase, proteases, metallopro-
teases, and a-amylases. These enzymes help to boost the eﬃciency of
absorption and digestion of nutrients [12]. Furthermore, bacteriocins
such as barnase and subtilin generated by B. amyloliquefaciens exhibit
antibacterial activity against pathogenic bacteria [13]. In recent times,
a number of studies have established that dietary supplementation of
B. amyloliquefaciens boost intestinal microﬂora, gut morphology, and
nutrient digestibility, thereby enhancing the growth rate and feed ef-
ﬁciency [14,15]. These positive eﬀects indicated that the B. amyloli-
quefaciens could also improve the health status of calves and dogs.
Therefore, the objective of this work is to evaluate the impact of
Bacillus amyloliquefaciens CECT 5940 on some pathogenic bacteria
shedding in dairy calves and adults dogs feed intake, body weight [16]
gain, and health conditions of Holstein calves fed with PWM and those
fed with NMR containing sodium-butyrate and active B. amyloliquefa-
ciens for 60 d. For a bacterium to be a viable probiotic, it must be
capable of surviving the acidic conditions of the intestinal tract and
colonizing or replicating in the large intestine freely. Although there are
several conventional probiotic supplements that can be used for dogs,
there are yet few controlled studies of the survival and inﬂuence of
probiotics in dogs [17]. This study also assessed the eﬀectiveness of B.
amyloliquefaciens CECT 5940 supplementation in dog diet at a daily
dose of 1 × 106 CFU/g, and survivability as it passes through the
gastrointestinal tract, colonizes the colon, and enhances the health
status.
2. Materials and methods
2.1. Experiment 1: Feeding of B. amyloliquefaciens CECT 5940 and
shedding of faecal bacteria in diary calves
This investigation was carried out on a commercial dairy farm in
Pabellón Arteaga (Aguascalientes, Mexico), and all experimental pro-
cedures were performed according to the standard ethics of the oﬃcial
Mexican standard of animals care (NOM-051-ZOO-1995) and the 1964
Helsinki declaration and its subsequent revision for comparable ethical
standards.
2.1.1. Calves management and feeding
Eighteen clinically healthy Holstein female calves with an initial
body weight of 41 ± 3.7 kg, born without congenital malformations
were detached from their mothers within 1–2 h from birth. Calves were
identiﬁed with an ear tag (Intelitec®, Intelitec S.A. de C.V., Mexico) and
fed colostrum (colostrum was pooled and then fed individually per calf)
by bottle (immunoglobins G (IgG); 70–100 mg/mL; analysed according
to [18] within the ﬁrst 2 h of life at the rate of 10% of their body
weight. Calves were then fed with 2 L colostrum every 12 h for three
days as a sole feed. Animals were accommodated in individual metal
pens (1.2 m × 1.5 m) bedded with sawdust, for an experimental period
of 60 d. Calves were randomly allotted to one of two dietary treatments:
pasteurized waste milk (PWM; n = 9) or formulated non-medicated
milk replacer (NMR; n = 9). The PWM used is raw milk obtained from
cows treated with antibiotics in addition to the accumulated non-sale-
able, transition milk and colostrum. The raw waste milk was heated to
70 °C for 15 sec and then cooled to 38 °C prior to feeding.
The milk replacer contained (g/kg dry matter (DM)): whey (471.0),
concentrated whey protein (52.8), pork fat (266.3), lactose (100.0), soy
protein isolate (100.0), lecithin SOLEC 3FeUB (3), vitamins and mi-
nerals (0.4), Allura red AC dye (0.5) and sodium-butyrate (6) plus a
probiotic (1) of active B. amyloliquefaciens CECT 5940 at 1 × 106 CFU/
g DM of probiotic (ECOBIOL®, Evonik Industries de Mexico SA de CV).
At every feeding time, NMR solution was prepared in steel buckets by
mixing 120 g of NMR powder with 1 L of warm water (45 °C). The NMR
solution was then cooled to 38 °C before serving. The calves were fed
individually twice daily at 0900 and 1600 h using the buckets
throughout the study according to the following protocol: day 4–20; 2 L
liquid, d 21 to 60; 3 L liquid per feeding per calf. On day 4, calves were
oﬀered pelleted starter feed (FOGASA, Aguascalientes, Mexico) once a
day in the morning at 0900 h. All the calves were giving fresh water ad
libitum. The feed and water intake, weight gain and health conditions
for each calf were observed.
2.1.2. Measurements and observations
The calves were weighed with a digital plate scale (Torrey® EQM,
México) on day 1, 15, 30, 45 and 60 of the experimental period. The
height of the calf (hoof to the back) was measured with a wooden ruler
(Garrott-Metre®, Pro-Vac Inc., Canada) on day 1, 15, 30, 45 and 60.
A faecal sample of 10 g per calf was obtained directly from the
rectum of each calf on day 1, 30 and 60. The samples were immediately
referred to the laboratory where plantings were done in a selective
media, diﬀerential and enriched anaerobically at 37 °C for 72 h to
quantify the colony-forming unit/g of E. coli (plated on sorbitol
MacConkey agar supplemented with ceﬁxime and potassium tellurite;
[19]. K. oxytoca and K. pneumoniae (plated on Simmon's citrate agar
with 1% inositol [20], P. mirabilis and P. vulgaris (plated in a medium
contained heart infusion agar supplemented with bile salts, lithium
chloride, sodium thiosulfate, and sodium citrate [21]; were also eval-
uated. The calves health were monitored daily, and the rating of in-
dividual calf faeces was scored as 1 (normal), 2 (pasty), 3 (semi) and 4
(liquids).
2.1.3. Statistical analysis
The PROC MIXED of SAS (version 9.0; SAS Institute, 2002) was used
for statistical analysis. The model contained “individual calf” as a
random eﬀect and “dietary treatment” (PWM or NMR (contain the
B. amyloliquefaciens CECT 5940)) as a ﬁxed eﬀect. All analyses were
performed individually, with veriﬁcation that the convergence criterion
was met, with the following model.
Yij = μ + Ti + Eij
where Yij is every observation of the jth calf assigned to ith treatment, μ
is the overall mean, Ti is the treatment eﬀect, and Eij is the residual
error.
To separate the least square means, the PDIFF SAS option was used;
P < 0.05 was declared as statistically signiﬁcant.
2.2. Experiment 2: Feed of B. amyloliquefaciens and shedding of faecal
bacteria in adult dogs
The experiment was carried out considering the animal welfare
standards of NOM 062 ZOO 1999 “Technical speciﬁcations for the
production, care and use of laboratory animals”.
P. Vazquez-Mendoza et al. Microbial Pathogenesis 114 (2018) 458–463
459
2.2.1. Dogs feeding and management
The dogs were housed in an individual kennel at a constant tem-
perature of 22 °C, from the Center for Research in Pet Food (CIAM)
located in Tepeji del Rio de Ocampo, Hidalgo, Mexico. The kennels
were equipped with a wooden platform for the rest of the animals and
had fresh water all the time.
Eight dogs were clinically healthy (Bichon Frize, 5 males, and 3
females) and were randomly assigned to two treatments group. The ﬁrst
is control group (without addition of B. amyloliquefaciens CECT 5940,
n = 4, live weight: 5.76 ± 1.49 kg). The second is probiotic group
(with addition of B. amyloliquefaciens CECT 5940, n = 4, live weight:
4.93 ± 0.56 kg) and the standard diet supplemented with the same
probiotic product used in the 1st experiment (i.e., B. amyloliquefaciens
CECT 5940, 1 × 109 CFU/g DM of product (ECOBIOL®, Evonik
Industries de Mexico SA de CV)). The feed was made with commercial
feed based on poultry, beef and pork meal, milled corn, soybean paste
and rice (Dog Chow adults small breeds; Nestlé Purina PetCare, Mexico)
with a nutritional contribution (%): crude protein (23), ethereal extract
(12), crude ﬁber (4), ash (8)). The amount of feed oﬀered per day was
calculated according to live weight following the recommendations of
the NRC [22]. Feed intake and probiotic supplementation were mon-
itored daily.
2.2.2. Experimental periods and probiotic supplementation
The animals were housed individually, fed once a day, the experi-
mental period was 30 days, with six days of previous adaptation (PP,
the period before addition of B. amyloliquefaciens CECT 5940) and seven
days of rest. From day 7–37 (EP, an experimental period during the
addition of B. amyloliquefaciens CECT 5940) supplemented with the
probiotic oﬀering the amount equivalent to 1 g of probiotic per kg of
food, with the aim of oﬀering the dog a dose of 1 × 106 CFU/g to the
food. The probiotic was added to the ration (on top) before being of-
fered. The probiotic comes in an odorless white powder, which fa-
cilitated its application. At day 37, the probiotic supplementation was
withdrawn for 7 d, then the same procedure was replicated by changing
the animals from the control (i.e., without B. amyloliquefaciens CECT
5940) group to the probiotic group (i.e. with B. amyloliquefaciens CECT
5940). The dosage of the treated food from day 44–71 was reinstalled
(FP, experimental ﬁnal period after adding the B. amyloliquefaciens
CECT 5940) and from day 72 to the last collection of faeces (day 77,
ﬁnal period) food was given without probiotic.
2.2.3. Faecal microbial count
The ﬁrst fresh faeces of the day were collected immediately after the
deposition of each animal during PP (day 7), EP (days 22 and 37) and
FP (day 42) and in the second stage faeces were collected in EP days 57
and 71) and FP (day 77). The samples were refrigerated and transported
in a maximum of 1 h to the microbiology laboratory of the Faculty of
Higher Studies Cuautitlán-UNAM. 1 g of a stool sample from each
period was taken and homogenized at 1% in a sterile (w/v) phosphate
medium and serially diluted to 10–9. In duplicate, 100 μL of this sus-
pension was taken and spread in a selective medium: Mac Conkey agar
(Dibico S.A. of C.V. Mexico D.F.) for total Enterobacteria and E. coli.
Petri dishes were incubated anaerobically (GasPak BBL anaerobiosis
jar, Becton Dickinson, NJ, USA) at 37 °C for 48 h. For the quantiﬁcation
of B. amyloliquefaciens the same procedure was followed, 100 μL in
duplicate were seeded in a selective medium: Soya agar and
Tripticaseina (Dibico SA de CV Mexico DF) enriched with 0.2% (w/v)
starch and incubated at 37 °C for 48 h, then counted visually. For
Clostridium spp. in duplicate, 100 μL of the suspension was taken and
seeded in boxes with selective medium: Tryptose sulﬁte Cycloserine
agar (Becton Dickinson, NJ, USA) were incubated with anaerobiosis at
37 °C for 48 h.
2.2.4. Dogs stool quality measurements
Stool consistency was measured during the evaluation periods (i.e.,
PP, PE, PF) in the two treatment application orders (i.e. CON-PRO,
PRO-CON) 5 times per week using the illustrated Nestlé Purina rating
system. Faeces were scored on a 1–7 scale in which Grade 1 represents
hard stools and Grade 7 represents liquid stools.
2.2.5. Statistical analysis
The microbiological count, stool score, Microsporum canis culture
and live weight was statistically evaluated using a completely rando-
mized design with repeated measures over time. The main eﬀects will
be the treatments (control) and Probiotic and sampling time (PP, Ep,
FP), and the interaction between treatment and time. The analysis of
variance was done using the GLM procedure of Minitab 16® to detect
the diﬀerences. The means were compared with the Tukey test
(α = 0.05).
3. Results and discussion
3.1. Eﬀect of B. amyloliquefaciens CECT 5940 on faecal bacteria in diary
calves
After 30 d of the experiment, PWM-calves had higher faecal E. coli
than NMR-calves (B. amyloliquefaciens CECT 5940 supplemented).
However, NMR-calves had faecal K. oxytoca and P. vulgaris. Both
P. vulgaris and K. oxytoca emerged at the day 1 of the experiment and
then disappeared from samples from day 30–60 in PWM-calves.
K. pneumoniae was not found in PWM-calves at day 60, while for NMR-
calves, it disappeared both on day 30 and 60 (Fig. 1).
The initial BW, colostrum IgG and total serum protein concentra-
tions of the calves are similar, indicating that the diﬀerences in per-
formance exhibited by the calves are not related to the diﬀerences in
the health status of the calves at the beginning of the study. However,
the NMR-calves, which was supplemented with B. amyloliquefaciens
CECT 5940 had higher faecal score and lower cough score than PWM-
calves (Fig. 2). The improved immune system with PWM-calves is
clearly observed, as the faecal score was decreased compare to NMR-
calves.
Throughout the experimental period, calves fed NMR had higher
content from P. vulgaris and K. oxytoca with a similar count of E. coli
than calves fed on PWM. This could be ascribed to the presence of
antibiotics in the PWM since the used PWM came from cows treated
with antibiotics. Moreover, based on the waste milk content, the PWM
contains higher concentrations of a protective immunoglobulin such as
IgG, IgA, and IgM. PWM exhibit nonspeciﬁc immune factors like leu-
kocytes, cytokines, growth factors, hormones, vitamins, lactoferrin, and
lysozyme than the NMR [2]. Moreover, the medium-chain fatty acids
with a strong antimicrobial eﬀects are abundant in milk fat but are
mostly absent from the mixture of fats used in most milk replacers [2].
Lee et al. [1] observed no diﬀerences in the health of calves without
mortality during their study, when claves were fed on whole milk or
NMR for 70 d.
3.2. Eﬀect of B. amyloliquefaciens CECT 5940 on shedding of faecal
bacteria in dogs
The control and probiotic-supplemented foods had slightly diﬀerent
water contents. No Bacillus counts were observed for both the supple-
mented and control diets until day 22 where>3 × 107 CFU/g
and> 104 CFU/g, respectively were observed. At the end of the
study,> 2 × 105 CFU/g and>104 CFU/g, respectively were observed.
Daily probiotic intake for the dogs during the probiotic phase was
aimed to be 1 × 106 CFU/g daily. This result shows that
B. amyloliquefaciens CECT 5940 can be added to dog diet eﬀectively.
The B. amyloliquefaciens survived the movement through the gastro-
intestinal tract of the dog and rapidly colonized the dog's intestine,
resulting in enrichment of colonic microﬂora and systemic and local
eﬀects [23]. The local eﬀect entails an increase in Bacillus count and a
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decrease in coliform count. The systemic eﬀect was observed in several
immunologic and hematologic parameters. No signiﬁcant change was
observed in the mean faecal score of the supplemented and the control
diet throughout the period of the experiment (Fig. 3).
Fig. 4 presents the Bacillus count for the supplemented and the
control diet. The Bacillus count of the supplemented diet is signiﬁcantly
higher than that of the control diet. The highest Bacillus count was
observed on day 22, the Bacillus count decreases signiﬁcantly after day
37, while it increases after day 44.
The signiﬁcantly high Bacillus count in the supplemented diet is
attributed to the resistance of the probiotics to the production process
[17]. This makes the actual Bacillus concentration in the diet
(> 3 × 107 CFU/g) to surpass the predicted value in the recipe
(1 × 106 CFU/g). However, this value decreased to about
2 × 105 CFU/g at the end of the experiment. Extreme care was ensured
in the production and storage of probiotics-supplemented diet to pre-
vent exposure to air, thereby maintaining lower moisture content than
the control diet. This was achieved by storing the supplemented diet in
Fig. 1. Faecal bacterial counts (log10 CFU/g faeces) after 1, 30 and 60 d of the experimental period of the individual Holstein calves fed pasteurized waste milk (PWM) or a formulated
non-medicated milk replacer (NMR) contained Bacillus amyloliquefaciens CECT 5940 for 60 d.
Fig. 2. Scores of Holstein calves faecal cultures in the presence of dietary
B. amyloliquefaciens CECT 5940. WB: with Bacillus, WnB: without Bacillus.
Fig. 3. Scores of dog faecal cultures in the presence of dietary B. amyloliquefaciens CECT 5940. WB: with Bacillus, WnB: without Bacillus.
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aluminum bags instead of using paper sacks, making the recoveries
greater than those reported in previous studies [24]. Therefore,
B. amyloliquefaciens CECT 5940 may not survive under production and
storage condition other than the one used in this study. Exclusion of
B. amyloliquefaciens CECT 5940 from the diet signiﬁcantly reduced the
Bacillus count due to the clearance of the probiotic bacteria from the
colon. This is vivid in Fig. 5 on day 84.
The eﬀect was visible on Soya agar and Tripticaseina. The total
number of coliforms were measured selectively (Fig. 5). At the begin-
ning of the experiment, the supplemented diet exhibits the highest
coliform count compared with the control diet, while the control diet
shows the highest at the end of the experiment (day 84). This shows
that the supplemented diet is healthier than the control diet. Coliforms
are faecal bacteria found in the digestive tracts of dogs. Water pollution
caused by these bacteria is capable of causing serious illness. Although,
most coliforms are not harmful, some rare E. coli strain (especially
0157:H7 strain) are deadly. E. coli 0157:H7 is commonly found in
sheep, cattle, pigs and chickens.
4. Conclusion
The study explored the eﬀect of B. amyloliquefaciens CECT 5940
addition to dairy calves and dogs' diet on the calves and dogs perfor-
mance. Feeding NMR to calves increased faecal K. oxytoca and
P. vulgaris counts in comparison to PWM-calves with more moisture in
faeces. The overall results indicate that NMR contained
B. amyloliquefaciens CECT 5940 could be used as a replacement product
to substitute PWM and improve the shedding of intestinal bacteria
without negative eﬀects on calf health.
The administration of the same probiotic (i.e., B. amyloliquefaciens
CECT 5940) to the dog diet has no signiﬁcant eﬀect on the hardness of
the stool. Meanwhile, the Bacillus count increases while the coliforms
count decreases upon B. amyloliquefaciens CECT 5940 administration.
This reveals that B. amyloliquefaciens CECT 5940 survived the gastro-
intestinal passage and rapidly colonized the dog intestine, which could
positively aﬀect the metabolism and composition of the intestinal mi-
croﬂora. These results show that B. amyloliquefacien CECT 5940 is a
promising probiotic with antimicrobial and bactericidal activities for
dairy calves and adult dogs.
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Fig. 4. Counts (log10 CFU/g) of viable bacillus in dog faecal cultures in the presence of dietary B. amyloliquefaciens CECT 5940. WB: with Bacillus, WnB: without Bacillus.
Fig. 5. Counts (log10 CFU/g) of viable coliforms in dog faecal cultures in the presence of dietary B. amyloliquefaciens CECT 5940. WB: with Bacillus, WnB: without Bacillus.
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